Executive summary. The 340B Drug Pricing Program lets eligible covered entities buy certain outpatient drugs at reduced prices, under program requirements.
Definition
The 340B Drug Pricing Program is a federal program that provides qualifying covered entities access to outpatient drugs at discounted prices.
Where this work lives in Attergo
Compliance and inventory teams use Attergo Compliance Tracing, policies, tasks, and inventory records to organize the work around a 340B review. Keep the records aligned to your organization’s approved policy, and bring in the program lead whenever an item needs judgment.
Eligibility, the patient definition, the purchasing arrangement, and the recordkeeping requirements all matter, and each transaction has to meet them on its own terms.
Review and follow up
Use current HRSA guidance, your written organizational policy, and qualified program advice for day-to-day decisions. Keep records showing why a transaction was handled under the program and how any question about it was resolved.
Final decisions stay with the role your organization holds accountable for them. Record the decision on the item, with the evidence behind it, so the next person to open it does not start over.
Frequently asked questions
Who should use this Attergo workspace?
The role that owns the next action leads it: a billing specialist, an authorization coordinator, an inventory lead, a pharmacist, a compliance lead, or a finance reviewer. Access follows the role your organization assigns.
Referenced standards and further reading
- HRSA: 340B Drug Pricing Program ↗Health Resources and Services Administration
Related articles
340B eligibility depends on dispense context →